Keyphrases
Treatment Response
100%
NSAID Treatment
100%
Alzheimer's Disease
100%
Endophenotype
100%
Alzheimer's Disease Clinical Trials
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
50%
Clinical Trials
40%
Mild Cognitive Impairment
30%
Specific Intent
30%
Prevention Trials
20%
Inflammation
20%
Cooperative Study
20%
Blood-based
20%
Anti-inflammatory Drugs
10%
Alzheimer's Disease Treatment
10%
Cancer Disease
10%
Proteomic Assay
10%
Cognitive Benefits
10%
Cognitive Decline
10%
Complex Disease
10%
Cognitive Loss
10%
Adverse Responders
10%
NSAID Drugs
10%
Biological Profile
10%
Heterogeneous Conditions
10%
Patient Selection
10%
Biorepository
10%
Existing Resources
10%
Human Studies
10%
Personalized Approach
10%
Clinically Significant
10%
Person-centered
10%
Innovative Methods
10%
Protective Effect
10%
Cognitive Performance
10%
Cardiovascular Disease
10%
Targeted Intervention
10%
Therapeutic Benefits
10%
Therapeutic Response
10%
Pharmacology, Toxicology and Pharmaceutical Science
Non-Steroidal Anti-Inflammatory Drug
100%
Alzheimer's Disease
100%
Alzheimer's Disease Clinical Trial
100%
Anti-Inflammatory Drug
45%
Clinical Trial
36%
Mild Cognitive Impairment
27%
Inflammation
18%
Diseases
18%
Human Study
9%
Biological Marker
9%
Malignant Neoplasm
9%
Cardiovascular Disease
9%